Joanne Kahlenberg is a Rheumatology/Immunology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
3rd Floor Taubman Center Recp A
Ann Arbor, MI 481095370
Telephone
734-647-5900Registry record last updated 7 Jul 2011.
Clinical trials
- Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20253 payments
- Biogen, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
37.6%B Lymphocyte Stimulator-specific Inhibitor10.7%Benlysta100%Part D<11 patientsTNF inhibitor9.2%Humira(Cf) Pen60%Inflectra40%Part D<11 patients+ 4 more classes in this area
Antiparasitic
33.9%Antimalarial33.9%Hydroxychloroquine Sulfate100%Part D≥34 patientsMetabolism & gastrointestinal
28.4%Corticosteroid25.1%Prednisone100%Part D≥16 patientsProton pump inhibitor3.4%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Integrated Program for Cutaneous Immune-Stromal Interactions in SLE (IPCISS)
University of Michigan at Ann Arbor
FY2026$1,520,330P01AI179251 - Hippo signaling as a critical regulator of lupus keratinocyte dysfunction
University of Michigan at Ann Arbor
FY2026$480,065R01AR081640 - Dissecting the Stromal-Immune Interactions that Lead to Photosensitivity (Project 2)
University of Michigan at Ann Arbor
FY2026$466,969P01AI179251
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”